Tat-beclin 1 combines a cell-penetrating motif with a regulatory peptide segment, enabling detailed investigation of protein-peptide interactions. Charge-rich residues enhance solubility and facilitate conformational adaptation. Researchers use the sequence to map binding interfaces and study motif-driven signaling. Applications include structural biology, peptide engineering, and biochemical pathway modeling.
CAT No: R2300
CAS No:1423821-88-8
Synonyms/Alias:Tat-beclin 1;1423821-88-8;
Tat-beclin 1 is a synthetic peptide chimera that fuses the HIV-1 Tat protein transduction domain with a critical region of the autophagy protein Beclin 1. Designed to facilitate cellular uptake and modulate autophagic pathways, Tat-beclin 1 has become a valuable research tool in the investigation of autophagy regulation and related intracellular processes. Its unique structure enables efficient delivery into a wide variety of cell types, making it particularly useful for probing the molecular mechanisms underlying autophagy induction, protein turnover, and cellular homeostasis in diverse experimental systems. The peptide's ability to interact with autophagic machinery positions it at the forefront of studies aiming to elucidate the interplay between autophagy and cellular stress responses.
Autophagy induction studies: Tat-beclin 1 is widely employed in research aimed at stimulating autophagic flux in mammalian cell lines and primary cultures. By mimicking a key region of Beclin 1, the peptide can promote the initiation of autophagy, allowing investigators to dissect the downstream effects of enhanced autophagic activity. This application is particularly valuable for elucidating the role of autophagy in cell survival, adaptation to stress, and the maintenance of cellular quality control under various experimental conditions.
Cellular pathway analysis: Researchers utilize Tat-beclin 1 to interrogate the signaling networks that regulate autophagy and related lysosomal pathways. The peptide's capacity to selectively activate autophagic processes provides a controlled experimental model for mapping the interactions between autophagy, mTOR signaling, and other metabolic regulators. Such studies contribute to a deeper understanding of how cells orchestrate degradation and recycling processes in response to nutrient availability, metabolic shifts, or environmental stressors.
Proteostasis and aggregate clearance research: The ability of Tat-beclin 1 to enhance autophagic activity makes it a powerful tool for investigating the mechanisms of protein quality control and aggregate clearance. By facilitating the removal of misfolded proteins and damaged organelles, the peptide enables detailed studies into the cellular strategies for maintaining proteostasis. This application is particularly relevant in models of protein aggregation, where modulation of autophagy can reveal insights into the clearance of toxic species and the preservation of cellular function.
Organelle dynamics and turnover: The peptide is frequently used to examine the turnover of specific organelles, such as mitochondria (mitophagy) or peroxisomes (pexophagy), within the context of autophagic regulation. By promoting autophagic sequestration and degradation of targeted organelles, Tat-beclin 1 assists researchers in characterizing the interplay between selective autophagy and organelle quality control. These studies are essential for understanding how cells adapt their organelle populations in response to metabolic demands or damage.
Drug discovery and screening assays: Tat-beclin 1 serves as a reference compound in high-content screening platforms designed to identify modulators of autophagy. Its well-characterized activity profile allows for the benchmarking of novel small molecules or biologics that target autophagic pathways. By providing a reliable means to induce autophagy in vitro, the peptide supports the development and validation of assays aimed at discovering new research tools and potential therapeutic leads for diseases associated with dysregulated autophagy.
2. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
5. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More